Immunex Corporation
Patent Owner
Stats
- 201 US PATENTS IN FORCE
- 2 US APPLICATIONS PENDING
- May 18, 2017 most recent publication
Details
- 201 Issued Patents
- 0 Issued in last 3 years
- 0 Published in last 3 years
- 10,444 Total Citation Count
- Aug 02, 1979 Earliest Filing
- 376 Expired/Abandoned/Withdrawn Patents
Patent Activity in the Last 10 Years
Technologies
Intl Class
Technology
Matters
Rank in Class
Top Patents (by citation)
Upgrade to the Professional Level to View Top Patents for this Owner. Learn More |
Recent Publications
Publication #
Title
Filing Date
Pub Date
Intl Class
2017/0096,471 SOLUBLE TUMOR NECROSIS FACTOR RECEPTOR TREATMENT OF MEDICAL DISORDERSSep 08, 16Apr 06, 17[C07K]
2017/0051,039 COMPOSITIONS COMPRISING A P75 TUMOR NECROSIS FACTOR RECEPTOR/IG FUSION PROTEINNov 02, 16Feb 23, 17[A61K, C07K]
Recent Patents
Patent #
Title
Filing Date
Issue Date
Intl Class
9518111 Compositions comprising a p75 tumor necrosis factor receptor/Ig fusion proteinSep 05, 14Dec 13, 16[A61K, C07K]
9045558 Nucleic acids encoding modified human thymic stromal lymphopoietinDec 03, 13Jun 02, 15[A61K, C12N, C07K]
8722631 Soluble tumor necrosis factor receptor treatment of medical disordersFeb 21, 13May 13, 14[A61K, C07K]
Expired/Abandoned/Withdrawn Patents
Patent #
Title
Status
Filing Date
Issue/Pub Date
Intl Class
2017/0137,526 USE OF INTERLEUKIN-4 ANTAGONISTS AND COMPOSITIONS THEREOFAbandonedJan 24, 17May 18, 17[C07K]
2014/0212,420 SOLUBLE TUMOR NECROSIS FACTOR RECEPTOR TREATMENT OF MEDICAL DISORDERSAbandonedMar 25, 14Jul 31, 14[A61K]
8058397 Family of immunoregulators designated leukocyte immunoglobulin-like receptors (LIR)ExpiredOct 14, 10Nov 15, 11[C07K]
8048994 C-type lectin polypeptide, polynucleotide and methods of making and use thereofExpiredApr 07, 10Nov 01, 11[C07K]
Top Inventors for This Owner
Upgrade to the Professional Level to View Top Inventors for this Owner. Learn More |
We are sorry but your current selection exceeds the maximum number of comparisons () for this membership level. Upgrade to our Level for up to -1 comparisons!
We are sorry but your current selection exceeds the maximum number of portfolios (0) for this membership level. Upgrade to our Level for up to -1 portfolios!.